IP Verse

Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders - EP2120568

PATENT ANALYSIS

Patent Details

Grant Date
Nov 15, 2017
Company
CELATOR PHARMACEUTICALS, INC.
Oppositions

GENERICS (U.K.) LIMITED

TEVA PHARMACEUTICAL INDUSTRIES LTD

More patents of Celator Pharmaceuticals, Inc.

EP3300601

EP2768484

EP2120568

Want to monitor this patent?

Feel free to send us a message here and we will get back to you